China Puzzled Over Cause Of Negative Avastin Reactions In Shanghai
This article was originally published in PharmAsia News
Executive Summary
Chinese authorities remained puzzled over the cause of adverse reactions among 61 Shanghai patients treated with Roche's Avastin (bevacizumab)